What does APOTHEEK PAMELSE KLEI do?

APOTHEEK PAMELSE KLEI is a pharmacy in Roosdaal. Private Limited, started on 30 September 1991, 1 establishment.

What is the address of APOTHEEK PAMELSE KLEI?

The registered office of APOTHEEK PAMELSE KLEI is located at Pamelse Klei 1, 1760 Roosdaal.

Is APOTHEEK PAMELSE KLEI still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PAMELSE KLEI is active, legal situation “Normale toestand”, started on 30 September 1991.

Is APOTHEEK PAMELSE KLEI registered on Peppol?

Yes, APOTHEEK PAMELSE KLEI is registered on the Peppol network with ID 0208:0445237027.

What is the enterprise number of APOTHEEK PAMELSE KLEI?

The enterprise number of APOTHEEK PAMELSE KLEI is BE0445237027.

When was APOTHEEK PAMELSE KLEI founded?

APOTHEEK PAMELSE KLEI was founded on 30 September 1991.

Who are the directors of APOTHEEK PAMELSE KLEI?

According to the 2025 annual accounts, the directors of APOTHEEK PAMELSE KLEI are: MedicIn BV.

Is APOTHEEK PAMELSE KLEI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 September 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PAMELSE KLEI make in 2025?

APOTHEEK PAMELSE KLEI posted a profit after taxes of € 57,055 in financial year 2025.

What is the revenue of APOTHEEK PAMELSE KLEI?

As a small company, APOTHEEK PAMELSE KLEI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 244,210.

How much does an employee at APOTHEEK PAMELSE KLEI earn?

The average wage cost per full-time employee at APOTHEEK PAMELSE KLEI was € 58,300 in 2025: staff costs of € 145,773 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK PAMELSE KLEI have?

According to the 2025 annual accounts, APOTHEEK PAMELSE KLEI has 2.5 full-time equivalents (FTE).

APOTHEEK PAMELSE KLEI (Private Limited) - Roosdaal

Dossier APOTHEEK PAMELSE KLEI, printed on 30 October 2026 from databakkes.be/en/0445237027/apotheek-pamelse-klei. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PAMELSE KLEI from Roosdaal, company number BE0445237027, closed financial year 2025 with a result of € 57,055 after tax. For that financial year APOTHEEK PAMELSE KLEI recorded a gross margin of € 244,210 and equity of € 322,079. Compared with financial year 2024, the result moved from € 55,749 to € 57,055. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 322,079

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 57,055

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 258,393

▲ € 194,402 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 47,000 paid out

82 % of the profit went to the shareholders, mostly to MedicIn (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.5

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 145,773

▲ 10% vs 2024

€ 58,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,591

▼ 13% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 166,395

▼ 12% vs 2024

€ 22,689 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 89,251

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,516

▼ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 220,878 Gross margin 2022: € 220,878 First fiscal year in the series	€ 181,505 Gross margin 2023: € 181,505 ▼ 18% vs 2022 (€ 220,878) Unfavourable step	€ 223,885 Gross margin 2024: € 223,885 ▲ 23% vs 2023 (€ 181,505) Favourable step	€ 244,210 Gross margin 2025: € 244,210 ▲ 9% vs 2024 (€ 223,885) Favourable step	▲ 9%
Profit after taxes	€ 80,308 Profit after taxes 2022: € 80,308 First fiscal year in the series	€ 49,530 Profit after taxes 2023: € 49,530 ▼ 38% vs 2022 (€ 80,308) Unfavourable step	€ 55,749 Profit after taxes 2024: € 55,749 ▲ 13% vs 2023 (€ 49,530) Favourable step	€ 57,055 Profit after taxes 2025: € 57,055 ▲ 2% vs 2024 (€ 55,749) Favourable step	▲ 2%
Equity	€ 388,746 Equity 2022: € 388,746 First fiscal year in the series	€ 301,276 Equity 2023: € 301,276 ▼ 23% vs 2022 (€ 388,746) Unfavourable step	€ 312,025 Equity 2024: € 312,025 ▲ 4% vs 2023 (€ 301,276) Favourable step	€ 322,079 Equity 2025: € 322,079 ▲ 3% vs 2024 (€ 312,025) Favourable step	▲ 3%
Total debts	€ 580,524 Total debts 2022: € 580,524 First fiscal year in the series	€ 667,839 Total debts 2023: € 667,839 ▲ 15% vs 2022 (€ 580,524) Unfavourable step	€ 601,753 Total debts 2024: € 601,753 ▼ 10% vs 2023 (€ 667,839) Favourable step	€ 614,870 Total debts 2025: € 614,870 ▲ 2% vs 2024 (€ 601,753) Unfavourable step	▲ 2%
Cash	€ 273,146 Cash 2022: € 273,146 First fiscal year in the series	€ 311,176 Cash 2023: € 311,176 ▲ 14% vs 2022 (€ 273,146) Favourable step	€ 63,991 Cash 2024: € 63,991 ▼ 79% vs 2023 (€ 311,176) Unfavourable step	€ 258,393 Cash 2025: € 258,393 ▲ € 194,402 vs 2024 (€ 63,991) Favourable step	▲ € 194,402
Land & buildings	€ 390,164 Land & buildings 2022: € 390,164 First fiscal year in the series	€ 376,455 Land & buildings 2023: € 376,455 ▼ 4% vs 2022 (€ 390,164) Unchanged	€ 362,745 Land & buildings 2024: € 362,745 ▼ 4% vs 2023 (€ 376,455) Unchanged	€ 349,036 Land & buildings 2025: € 349,036 ▼ 4% vs 2024 (€ 362,745) Unchanged	▼ 4%
Retained profit	€ 370,154 Retained profit 2022: € 370,154 First fiscal year in the series	€ 282,684 Retained profit 2023: € 282,684 ▼ 24% vs 2022 (€ 370,154) Unfavourable step	€ 293,433 Retained profit 2024: € 293,433 ▲ 4% vs 2023 (€ 282,684) Favourable step	€ 303,487 Retained profit 2025: € 303,487 ▲ 3% vs 2024 (€ 293,433) Favourable step	▲ 3%
Dividend	€ 68,500 Dividend 2022: € 68,500 First fiscal year in the series	€ 137,000 Dividend 2023: € 137,000 ▲ 100% vs 2022 (€ 68,500) Unchanged	€ 45,000 Dividend 2024: € 45,000 ▼ 67% vs 2023 (€ 137,000) Unchanged	€ 47,000 Dividend 2025: € 47,000 ▲ 4% vs 2024 (€ 45,000) Unchanged	▲ 4%
Bank debt	€ 233,613 Bank debt 2022: € 233,613 First fiscal year in the series	€ 211,135 Bank debt 2023: € 211,135 ▼ 10% vs 2022 (€ 233,613) Favourable step	€ 188,531 Bank debt 2024: € 188,531 ▼ 11% vs 2023 (€ 211,135) Favourable step	€ 166,395 Bank debt 2025: € 166,395 ▼ 12% vs 2024 (€ 188,531) Favourable step	▼ 12%
Balance sheet total	€ 969,270 Balance sheet total 2022: € 969,270 First fiscal year in the series	€ 969,115 Balance sheet total 2023: € 969,115 Unchanged (€ 969,270) Unchanged	€ 913,777 Balance sheet total 2024: € 913,777 ▼ 6% vs 2023 (€ 969,115) Unchanged	€ 936,949 Balance sheet total 2025: € 936,949 ▲ 3% vs 2024 (€ 913,777) Unchanged	▲ 3%
Employees (FTE)	1.4 Employees (FTE) 2022: 1.4 First fiscal year in the series	1.1 Employees (FTE) 2023: 1.1 ▼ 0.3 vs 2022 (1.4) Unchanged	2.9 Employees (FTE) 2024: 2.9 ▲ 1.8 vs 2023 (1.1) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▼ 0.4 vs 2024 (2.9) Unchanged	▼ 0.4

Key figures of APOTHEEK PAMELSE KLEI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PAMELSE KLEI?

What happened at APOTHEEK PAMELSE KLEI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 57,055 (▲ 2% vs 2024). Source: NBB ↗
Nov 28, 1991 New establishment in Roosdaal. KBO
Sep 30, 1991 Start of the company according to the CBE. KBO

In short

From € 80,308 profit in 2022 to € 57,055 profit in 2025.

Paid € 17,060 in corporate taxes since 2022.

Best year ever: 2022, with € 80,308 profit.

On average € 97,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MedicIn 100%

The stake of MedicIn comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PAMELSE KLEI

Behind APOTHEEK PAMELSE KLEI is MedicIn BV. The shares are held by MedicIn (100%).

Directors

According to the 2025 annual accounts

MedicIn BV

Director · represented by Maaike Demeyere

Shareholders

MedicIn

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Pamelse Klei 1

1760 Roosdaal

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0445.237.027

VAT number

BE 0445.237.027

Registered office

Pamelse Klei 1, 1760 Roosdaal

Names & denominations

APOTHEEK PAMELSE KLEI

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 September 1991

Peppol

Active · Active since 1 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PAMELSE KLEI

Financials

What happened to APOTHEEK PAMELSE KLEI?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions